Jenny’s Immunotherapy Story May 22, 2018December 14, 2022 CRI Staff Lymphoma There’s life during cancer, too. Especially when I was doing immunotherapy. Jenny’s Story Jenny was still in college when she learned she had advanced Hodgkin lymphoma. Her mother researched immunotherapy clinical trial options and helped Jenny become her own patient advocate. She enrolled in a trial testing a combination of the anti-PD-1 checkpoint inhibitor nivolumab (Opdivo®) along with the antibody-drug conjugate brentuximab vedotin (Adcentris®). Read more: Post navigation Jami’s Immunotherapy Story Read Story Creating for the Cure: An Epic Podcast Fundraising Event Read Story